Sector: Pharmaceuticals & Biotechnology

Large Cap

Ipca Laboratories Share Price

IPCALAB

₹1,780.10

9.70(0.55%)

10th Jul 2026 | 3:28 PM

NSE : IPCALAB

Open Free Demat Account

Ipca Laboratories Performance

Price Movement

₹1780.10

₹1741.00

₹1799.40

↘ Today's Low↗ Today's High

1 Year Performance

₹1780.10

₹1251.60

₹1812.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,799.40

Low₹1,741.00

Open at₹1,788.00

Prev Close₹1,770.40

Volumes1.47 L

Avg Price₹1,771.49

Lower Circuit₹1,416.40

Upper Circuit₹2,124.40

Historical Performance

3M High₹1,812.50

3M Low₹1,431.40

1 Yr High₹1,812.50

1 Yr Low₹1,251.60

3 Yr High₹1,812.50

3 Yr Low₹748.95

5 Yr High₹1,812.50

5 Yr Low₹669.80

Summary

As of 10-07-2026 20:23, Ipca Laboratories Ltd. share price today is ₹0, with a change of ₹-1770.40 (-100.00%) from the previous close of ₹1770.4. The stock opened at ₹1788 and traded between ₹1741 and ₹1799.4, with a total traded volume of 146840 shares. The company has a market capitalization of ₹44915.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1812.5 and ₹1251.6, respectively.

Ipca Laboratories Ltd. valuation metrics include a P/E ratio of 39.4, EPS of ₹46.94, and book value of ₹5.60. Profitability indicators show ROE of 14.15% along with a dividend yield of 0.1%. Ipca Laboratories Ltd. has reported revenue of ₹9646.33 Cr and net profit of ₹1141.12 Cr.

Ipca Laboratories Ltd. technical indicators include Day RSI at 69.56, Day MFI at 88.04, Day ADX at 35.29. Additional indicators include Commodity Channel Index (CCI) at 107.2 and Williams %R at -15.59. Momentum indicators show Day MACD at 52.88, Day MACD Signal Line at 38.89, DayATR at 51.53. Rate of Change indicators for Ipca Laboratories Ltd. include ROC125 at 26.1 and ROC21 at 8.35.

Exponential moving averages include EMA5 at ₹1762.1, EMA10 at ₹1730.5, EMA12 at ₹1719, EMA20 at ₹1684.3, EMA26 at ₹1666.2, EMA50 at ₹1620.6, EMA100 at ₹1568.4, EMA200 at ₹1513.4. Simple moving averages include SMA5 at ₹1777.4, SMA10 at ₹1727, SMA20 at ₹1655.2, SMA30 at ₹1630.8, SMA50 at ₹1607.2, SMA100 at ₹1555, SMA150 at ₹1520.9, SMA200 at ₹1476.6.

Support levels for Ipca Laboratories are placed at First Support ₹1755.87, Second Support ₹1741.33, Third Support ₹1720.67. Resistance levels are seen at First Resistance ₹1791.07, Second Resistance ₹1811.73, Third Resistance ₹1826.27. Ipca Laboratories Ltd. shareholding pattern shows promoter holding at 44.72%, FII holding at 10.63%, DII holding at 0%, public holding at 7.21%.

Ipca Laboratories Fundamentals

Market Cap

High in industry

44,915.80 Cr.

PE Ratio (TTM)

Above industry Median

39.40

Dividend Yield

Low in industry

0.10

Net Profit TTM

54.7% incr over last year

1,141.12

Net Profit Growth

54.7% incr over last year

1,141.12

PEG Ratio

Above industry Median

0.70

ROE

33.4% incr over last year

14.15

Operating Revenue TTM

9,646.33

Operating Revenue Growth

7.9% incr over last year

Book Value

Above industry Median

5.60

MFI

MFI strongly Overbought

88.04

RSI

RSI is mid-range

69.56

EPS (TTM)

46.94

Debt to Equity

0.09

Face Value

Operating Profit Margin Qtr.

20.15

Operating Profit Qtr.

483.87

Net Profit Qtr.

299.07

Operating Revenue Qtr.

2,388.48

PB Ratio

5.60

Ipca Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	1,814.35	1,845.18	1,930.32	1,746.90	1,638.44
Operating Expense	1,383.17	1,367.70	1,465.61	1,339.98	1,279.85
Operating Profit	431.18	477.48	464.71	406.92	358.59
Depreciation	70.31	68.57	66.86	63.13	65.19
Interest	10.48	9.51	11.46	12.06	16.20
Tax	87.56	113.77	103.57	94.71	82.20
Net Profit	262.29	303.45	304.74	262.04	-65.05

Ipca Laboratories Technicals

Ipca Laboratories Ltd. EMA & SMA

₹1780.10

17.70 (1.00%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1762.1

Day EMA10 ₹1730.5

Day EMA12 ₹1719

Day EMA20 ₹1684.3

Day EMA26 ₹1666.2

Day EMA50 ₹1620.6

Day EMA100 ₹1568.4

Day EMA200 ₹1513.4

Ipca Laboratories Support and Resistance

Resistance

First Resistance₹1791.07

Second Resistance₹1811.73

Third Resistance₹1826.27

Support

First Support₹1755.87

Second Support₹1741.33

Third Support₹1720.67

Technical Indicators

Day RSI69.56

Day MFI88.04

Day ADX35.29

Day Commodity Channel Index107.20

William-15.59

Day MACD52.88

Day MACD Signal Line38.89

Day ATR51.53

Day ROC12526.10

Day ROC218.35

Ipca Laboratories Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	44.7	44.7	44.7	44.7	44.7	44.7
FII	11.1	10.8	10.7	10.4	10.6	10.6
DII	35.6	36	36.2	36.8	37.3	37.5
Public	8.5	8.4	8.4	8.1	7.3	7.2

Ipca Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	46.59 K	1.03 L	45.02%
Week	1.55 L	2.84 L	54.69%
1 Month	1.39 L	2.54 L	54.76%
6 Month	1.72 L	2.96 L	58.23%

Ipca Laboratories SWOT Analysis

Strengths24

Weakness5

Opportunity3

Threats0

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Stocks with High Durability and EPS growth (subscription)

Strong Momentum: Price above short, medium and long term moving averages

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

RSI indicating price strength

Top Gainers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Ipca Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
05 Aug, 2025	2	FINAL	05 Aug, 2025	Equity Share
25 Nov, 2024	2	INTERIM	25 Nov, 2024	Equity Share
06 Aug, 2024	2	FINAL		Equity Share
22 Nov, 2023	2	INTERIM	22 Nov, 2023	Equity Share
22 Nov, 2022	4	INTERIM	23 Nov, 2022	Equity Share
22 Nov, 2021	8	INTERIM	23 Nov, 2021	Equity Share
13 Nov, 2020	8	INTERIM	17 Nov, 2020	Equity Share
18 Feb, 2020	5	INTERIM	20 Feb, 2020	Equity Share
06 Aug, 2019	3	FINAL		Equity Share
02 Aug, 2018	1	FINAL		Equity Share

Ipca Laboratories Stock Comparison

Financials	Rubicon Research Ltd.	Anthem Biosciences Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,429	₹754.95	₹1,265	₹1,805	₹2,523	₹176.50
% Change	1.55%	0.39%	2.48%	-0.25%	-0.36%	2.62%
Revenue TTM (₹ Cr)	₹1,753.96	₹2,124.33	₹2,192.49	₹9,203.54	₹14,277.64	₹8,869.07
Net Profit TTM (₹ Cr)	₹246.74	₹591.79	₹348.91	₹924.36	₹1,912.93	₹-325.93
PE TTM	94.30	71.60	75.10	37.10	54.70	-70.30
1 Year Return	190.14	31.93	57.98	43.82	0.21	-14.62
ROCE	24.32	27.56	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3390.00

-1.99%

GLAND

Gland Pharma Ltd.

₹ 2475.00

+0.22%

LAURUSLABS

Laurus Labs Ltd.

₹ 1535.50

+1.86%

ALKEM

Alkem Laboratories Ltd.

₹ 5676.00

+0.49%

BIOCON

Biocon Ltd.

₹ 418.25

+3.64%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6830.50

+0.26%

GRANULES

Granules India Ltd.

₹ 887.00

+0.56%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3366.00

+1.77%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1152.10

-0.60%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2284.50

+0.76%

WOCKPHARMA

Wockhardt Ltd.

₹ 1812.80

-1.01%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1568.90

-1.17%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1932.90

-0.30%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 19478.00

-0.33%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2420.00

-1.00%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8115.00

+0.01%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2433.00

-0.30%

PFIZER

Pfizer Ltd.

₹ 4720.00

+2.83%

ABBOTINDIA

Abbott India Ltd.

₹ 27340.00

+2.13%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4890.00

-0.17%

LUPIN

Lupin Ltd.

₹ 2496.00

-0.29%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1246.90

-1.78%

CIPLA

Cipla Ltd.

₹ 1442.00

+0.05%

FAQ's on IPCALAB

What is the current share price of Ipca Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Ipca Laboratories Ltd. is ₹ 1780.1 on the NSE and ₹ 1786.75 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Ipca Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ipca Laboratories Ltd. is approximately ₹ 44915.8 Cr.

What are the PE and PB ratios for Ipca Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ipca Laboratories Ltd. is 39.4, and the Price-to-Book (PB) ratio is 5.6.

What is the 52-Week High and Low for Ipca Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Ipca Laboratories Ltd. shares was ₹ 1812.5, and the lowest price was ₹ 1251.6.

What is the current dividend yield for Ipca Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Ipca Laboratories Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Ipca Laboratories Ltd.?

Significant shareholdings in Ipca Laboratories Ltd. typically include entities such as:

Promoter
Mutual Funds
FII
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Ipca Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ipca Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Ipca Laboratories Ltd.?

Ipca Laboratories Ltd. last declared a FINAL dividend of ₹ 2 per share for the financial period ending 2025. The record date was set as 2025-08-05, and the payment was/is scheduled around 2025-08-05. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy